Datavault AI Inc. shares fell $0.49, or 19.44%, to close at $2.03 on October 31, 2025, after Wolfpack Research questioned the value of purported partnerships and said trading activity on the Datavault Platform appeared minimal, if not nonexistent. The pending securities class action covers investors who purchased or otherwise acquired Datavault AI securities under NASDAQ ticker DVLT from September 4, 2024, through October 30, 2025, inclusive. Rosen Law Firm and Glancy Prongay Wolke & Rotter LLP said October 5, 2026, is the deadline to seek appointment as lead plaintiff. The complaint alleges that Datavault AI and other defendants overstated the economic value of partnerships involving Burke Products, Scilex Holding Company and Nature's Miracle Holding Inc., overstated platform trading activity, and failed to disclose connections with Edward Withrow III, a convicted felon, that allegedly could cause reputational harm. The allegations have not been proven, no class has been certified, and investors may retain counsel, remain absent class members or take no action. The materials also cite a proposed $150 million Scilex investment, a Nature's Miracle license with a $2 million non-refundable fee and 35% royalty, a Burke partnership linked to a U.S. defense market whose budget was cited as exceeding $900 billion, alleged financial and contract limitations at those companies, a $210 million Datavault Platform intellectual-property purchase, and more than $73.8 million in alleged insider stock-sale proceeds.